Document is current
Any future updates will be listed below
-
Authors
Traoré, Isidore Tiandiogo
Ouedraogo, Samiratou http://orcid.org/0000-0001-8224-5543
Kania, Dramane
Kaboré, Firmin Nongodo
Konaté, Blahima
Médah, Rachel
Badolo, Hermann
de Rekeneire, Nathalie
Kamga, Ariane Mamguem
Poda, Armel
Diendere, Arnaud Eric
Ouédraogo, Boukary
Ouédraogo, Esperance
Billa, Oumar
Tinto, Halidou
Dabakuyo-Yonli, Tienhan Sandrine
-
Funding
Funding for this research was provided by:
Agence Nationale de Recherches sur le Sida et les Hépatites Virales (ANRS-COV13 / EMuLCOVID-19)
Institute of Population and Public Health (CIHR-IRSC:0579001152)
Institut National de Santé Publique du Québec
McGill University Health Centre
- License Information
-
More Information
Article History
Received: 14 June 2021
Accepted: 6 August 2021
First Online: 3 September 2021
Declarations
:
: This project has been approved by the Ministry of Health (N° 2020-00952/MS/CAB/INSP/CM) and the national committee for health research of Burkina Faso (N° 2020-8-140). The study will be performed in compliance with the latest revised version of the Helsinki Declaration [CitationRef removed], current legislation in Burkina Faso regarding clinical research, and the principles of Good Laboratory Practice and Good Clinical Practice [CitationRef removed]. Apart from emergency situations requiring the initiation of specific therapies, the investigators and their designated representatives commit to respecting every aspect of the study protocol, particularly concerning the collection of informed consent and the notification and follow-up of adverse events. All study participant to the study, will provide signed consent.
: Not applicable.
: The authors declare that they have no competing interests.
